Profiel
Aaron Foster served as Senior Vice President & Head-Research at Bellicum Pharmaceuticals, Inc. and as Assistant Professor-Center for Cell & Gene Therapy at Baylor College of Medicine.
Prior to that, he received an undergraduate degree from the University of Puget Sound in 1994 and a doctorate degree from The University of Sydney in 2003.
Eerdere bekende functies van Aaron Foster
| Bedrijven | Functie | Einde |
|---|---|---|
| Baylor College of Medicine | Corporate Officer/Principal | 01-01-2012 |
| BELLICUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Aaron Foster
| University of Puget Sound | Undergraduate Degree |
| The University of Sydney | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
